...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Biotech Showcase January 8-10, 2018

This presentation is 45 minutes after the market closes tomorrow, I wonder whether there will be anything earth shattering revealed?

tada

Share
New Message
Please login to post a reply